A Powerful Approach for Understanding Kinase and Phosphatase Function and Identifying the Most Effective Drugs

AssayQuant’s mission is to support the development of more effective therapies for cancer, chronic inflammation, neurodegeneration, and other serious conditions. Our team is motivated by a shared vision of reducing suffering, to build a healthier world. We stand with you at the frontier of target biology and drug discovery & development, helping you to rapidly and effectively identify the best solutions, from the vast number of possibilities.

AssayQuant's Proprietary PhosphoSens® Technology uses novel, fluorogenic sensors in enzyme recognition sequences that are carefully optimized for each enzyme to relay quantitative information on phosphorylation in real-time with less effort.

  • Our direct, real-time, kinetic, enzyme activity assays yield better, more reliable data than other methods, enabling better decisions regarding target biology and generation of lead candidates to empower faster movement through the drug discovery process.
  • Whether used in high, moderate or low throughput modes, the resulting richer information from quantitative data allows you to rapidly rank candidates by inhibition mechanism, selectivity profiling and multiple measures of potency, with covalent and reversible inhibitors and fragments.
  • AssayQuant has a catalog of over four hundred optimized assays, developed from curated libraries of tens of thousands of fluorogenic peptide sensor substrates, and also provides services to develop novel optimized assays for you. Why not use the best substrate for your assays, designed for your enzyme?
  • We will either transfer the new assay methods to you to use in your own laboratory or can provide screening, potency or profiling services, saving you time, money, and resources. Our highly skilled scientists bring years of experience with kinases and phosphatases to bear to solve your problems. Our goal is to help you get to the best candidate molecules with the highest efficacy as quickly as possible.
What's New
AssayQuant News, Latest Innovations & More
AssayQuant News
Development of a Real-Time, Fluorescence Microplate Assay for Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Activity
Epidermal Growth Factor Receptor (EGFR) wild-type and mutant tyrosine kinase activity and the downstream signaling cascades are pivotal in oncogenesis, drug resistance and tumor recurrence....
Read More >
Kinase & Phosphatase Drug Development
On-Demand Video: Kinase & Phosphatase Drug Development with PhosphoSens Activity-Based Sensors
Erik Schaefer, Ph.D., President, CEO & CSO presented on our PhosphoSens Technology capabilities to enable characterization of target biology and more effective development of new kinase and phosphatase drugs....
Read More >
Biochemical Characterization
Biochemical Characterization of Tirabrutinib and Other Irreversible Inhibitors of Bruton's Tyrosine Kinase (BTK) Reveals Differences in On - and Off – Target Inhibition
Analysis of the inactivation kinetics yielded a more accurate measurement of potency and selectivity than conventional single-time point inhibition measurements....
Read More >

Committed to Innovation

AssayQuant is a life science company founded by scientists who are committed to innovation. Through our advancements in assay design, we are transforming the way science gets done to deliver breakthrough discoveries needed to improve human health.